Anxiety, Quality of Life
Conditions
Keywords
COPD, Pulmonary rehabilitation, Neuromuscular electrical stimulation
Brief summary
Chronic obstructive pulmonary disease (COPD) contributes significantly to global morbidity and mortality; It is a disease that affects an estimated 210 million people worldwide and is the third most common cause of death. COPD is identified by persistent airflow limitation and is associated with progressively worsening lung function, dyspnea, health-related quality of life (HRQOL), and impaired exercise capacity. Poor exercise capacity is a common finding of chronic obstructive pulmonary disease (COPD). Central cardiopulmonary factors, respiratory muscle dysfunction, gas exchange abnormalities, and skeletal muscle dysfunction all play a role in limiting exercise capacity The aim of this study is to investigate the effects of neuromuscular electrical stimulation applied to different muscle groups (quadriceps femoris and gastrocnemius muscles) on exercise performance and quality of life in patients with stable COPD and compare it with standard treatment.
Interventions
DEVICEMuscle strengthening with neuromuscular electrical stimulation
The effect of peripheral muscle strengthening training in addition to pulmonary rehabilitation in COPD patients on the patient's performance will be examined.
Sponsors
Hitit University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Being between 18-75 years old, * Diagnosed as group B stable COPD according to GOLD criteria by a pulmonologist, * PaO2 \>55 mm Hg, PaCO2 \<45 mmHg in room air.
Exclusion criteria
* Exacerbation, * Cor pulmonale or respiratory muscle fatigue (abdominal paradoxical breathing), * Cardiac instability (with acute MI, congestive heart failure, or uncontrollable arrhythmia), * Musculoskeletal disorder (conditions affecting exercise ability), * Difficulty communicating.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 6 Minute Walk Test (6 MWT): | 4 weeks | they could walk for 6 minutes, according to heart rate, blood pressure, respiratory rate, finger oxygen saturation, the walking distance at the end of walking, and dyspnea score according to the Modified Borg Scale (MBS) at the beginning and end of walking was recorded. Change from baseline 6 Minute walking performance after 4 weeks will be examined. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Modified Borg Scale (MBS): | 4 weeks | It consists of 10 items that define the severity of dyspnea according to their degrees. Change from baseline dyspnea after 4 weeks will be examined. |
| St. George's Respiratory Questionnaire (SGRQ): | 4 weeks | This questionnaire was developed specifically to determine the severity of the disease in COPD and asthma. Change from baseline severity of the disease after 4 weeks will be examined. |
| Beck Depression Inventory (BDI): | 4 weeks | It measures the behavioral findings of depression in adolescents and adults. Change from baseline depression status after 4 weeks will be examined. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactAhmet Payas, Dr
Outcome results
None listed